Prosecution Insights
Last updated: October 04, 2026

Claw Biotech Holdings LLC

Technology area: Biotechnology & Pharmaceuticals

3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready

Analysis

Claw Biotech Holdings LLC has 1 pending office action. The portfolio involves 1 distinct examiner, SUSAN T TRAN, who is the busiest examiner for the 1 pending office action. There are 0 distinct art units associated with this profile. With 1 distinct examiner and 0 distinct art units, the prosecution is concentrated on 1 official. Practitioners should focus on the specific requirements of SUSAN T TRAN to resolve the 1 pending office action.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (67%)
1
Medium (33%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (33%)
§103 only1 (33%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
33% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TRAN, SUSAN T 1 62.8% +35.1%
KIM, DANIELLE A 1 37.1% +56.3%
ALLEY, GENEVIEVE S 1 60.3% +48.2%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18277403 ANTI-PATHOGENIC LIQUID COMPOSITIONS KIM, DANIELLE A 10d overdue
18986536 ANTI-PATHOGEN COMPOSITIONS TRAN, SUSAN T —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18277403 ANTI-PATHOGENIC LIQUID COMPOSITIONS KIM, DANIELLE A 10d overdue
18986536 ANTI-PATHOGEN COMPOSITIONS TRAN, SUSAN T —
18229265 PATHOGEN ELIMINATING ARTICLE FOR TREATING AGRICULTURAL PRODUCTS AND METHODS OF MANUFACTURING AND USING THE SAME ALLEY, GENEVIEVE S —

Top Art Units

Art UnitApps
1613 1
1617 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18986536 ANTI-PATHOGEN COMPOSITIONS TRAN, SUSAN T — §102§112Other Non-Final OA — Pending Dec 18, 2024
18277403 ANTI-PATHOGENIC LIQUID COMPOSITIONS KIM, DANIELLE A 1613 §101§102§103Other Final Rejection 10d overdue Pending Aug 16, 2023
18229265 PATHOGEN ELIMINATING ARTICLE FOR TREATING AGRICULTURAL PRODUCTS AND METHODS OF MANUFACTURING AND USING THE SAME ALLEY, GENEVIEVE S 1617 §103 Non-Final OA — Pending Aug 02, 2023

Managing Claw Biotech Holdings LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month